Skip to content
Screener

Lipocine LPCN Q1 2026 earnings

Reported May 7, 2026 · Before market open

Revenue$1.2MBeat by $1.0M
EPS-$0.54Miss by $0.03
Revenue estimate$162.5K
EPS estimate-$0.51

Next report

Nov 5, 2026 (in a month)
Revenue estimate$159.5K
EPS estimate-$0.39

FAQ

When did Lipocine report Q1 2026 earnings?
Lipocine (LPCN) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Lipocine's Q1 2026 revenue and EPS?
Lipocine reported revenue of $1.2M and eps of $-0.54 for Q1 2026.
Did Lipocine beat estimates in Q1 2026?
Revenue beat the consensus estimate of $162.5K by $1.0M. EPS missed the consensus estimate of $-0.51 by $0.03.
How did Lipocine's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1172.0% from $93.9K a year earlier and eps declined 54.3% from $-0.35.
Where can I find Lipocine's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-021638) and the 10-Q periodic report (0001493152-26-021637) directly on SEC EDGAR. The filing index links above go to sec.gov.